netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Recent Updates - Updated items

All Formulary Amendments

  Records 1 to 11 of 11


Details
UPD sitematrix Changed from 0 to
20/11/2023 13:04:42
(DavidS )
UPD FurtherInformation Changed from
20/11/2023 13:04:42
(DavidS )
UPD Enzalutamide updated formatting
20/11/2023 13:04:42
(DavidS )
LDL Link Added : NICE TA712: Enzalutamide for treating hormone-sensitive metastatic prostate cancer : https://www.nice.org.uk/guidance/ta712
15/12/2021 12:08:25
(DavidS )
UPD sitematrix Changed from 0 to
15/12/2021 12:08:07
(DavidS )
UPD FurtherInformation Changed from
  • Approved for use in adults with metastatic hormone-relapsed prostate cancer, who have not had chemotherapy in line with NICE.
to
15/12/2021 12:08:07
(DavidS )
UPD Enzalutamide NICE TA712
15/12/2021 12:08:07
(DavidS )
UPD Enzalutamide updated formatting
30/01/2018 12:06:41
(DavidS )
UPD Enzalutamide b
25/01/2017 09:19:45
(WhitehallJ )
UPD Enzalutamide b
25/01/2017 09:19:33
(WhitehallJ )
UPD Enzalutamide (Xtandi®) build
29/11/2016 09:31:05
(DavidS )

 

 
netFormulary